RiduZone receives acknowledgement from the US FDA

The US Food and Drug Administration (FDA) has issued an acknowledgement letter to NutriForward in response to their New Dietary Ingredient (NDI) Notification on the patented product RiduZone.

RiduZone is a naturally occurring appetite regulator that supports healthy weight, appetite and body fat composition in adults.

RiduZone is a metabolite of oleic acid, which is part of a healthy daily diet. After review of NDI Notification on RiduZone, FDA acknowledged: 'The ingredient is a metabolite of oleic acid, which is part of a daily diet. In addition, safety studies were provided on the product of commerce which indicates that RiduZone will reasonably be expected to be safe.'

Unlike other weight control supplements, RiduZone gives the body more of what it already makes - oleoylethanolamide (OEA). OEA is a natural metabolite made in the small intestine that helps to regulate hunger.

In essence, OEA tells the brain that the body is full and that it's time to stop eating. By taking RiduZone 30 minutes before breakfast and dinner, consumers will feel more full during meals and as a result will likely eat less. 'It's amazing that you can treat your taste buds without taxing your body with too many calories,' stated Shashi Marulappa, CEO of NutriForward.

NutriForward, the company behind RiduZone, has exclusive rights to bring OEA to market. Their team of scientists and doctors developed RiduZone to deliver OEA more efficiently and effectively through daily capsules.

'When it comes to losing weight, appetite control can be your biggest challenge or greatest asset,' said Dr Jay N. Yepuri, a board-certified gastroenterologist. 'Finally, there is a natural, effective way to supplement a healthy appetite, weight and body fat composition by going directly to your body's hunger regulator. RiduZone is my recommendation to any patient who is looking for a natural and effective way to look and feel great.'

NutriForward will release RiduZone in October 2015.